Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)

SHE:300289 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	574.79	566.02	574.27	565.02	798.81	928.6
Trading Asset Securities	-	336.75	316.14	290.29	-	-
Cash & Short-Term Investments	574.79	902.77	890.41	855.32	798.81	928.6
Cash Growth	-36.04%	1.39%	4.10%	7.07%	-13.98%	163.41%
Accounts Receivable	398.38	92.32	99.02	149.76	184.48	232.4
Other Receivables	57	12.88	19.56	2.4	6.05	5.67
Receivables	455.38	105.2	118.58	152.16	190.52	238.08
Inventory	100.92	88.72	89.45	88.28	97.44	102.48
Other Current Assets	743.6	5.36	8.71	9.93	23.73	9.96
Total Current Assets	1,875	1,102	1,107	1,106	1,111	1,279
Property, Plant & Equipment	565.96	373.7	402.3	427.68	458.68	474.96
Long-Term Investments	0.91	10.72	11.17	23.66	20.9	1.01
Goodwill	785.04	73.53	73.53	144.66	159.54	190.07
Other Intangible Assets	89.83	20.98	25.17	28.74	33.89	37.74
Long-Term Accounts Receivable	4.88	7.42	1.17	-	-	-
Long-Term Deferred Tax Assets	76.51	41.07	46.93	43.06	35.52	27.95
Long-Term Deferred Charges	34.01	5.6	12.02	17.23	24.56	26.15
Other Long-Term Assets	141.1	141.1	142.99	147.69	156.22	311.41
Total Assets	3,573	1,776	1,822	1,938	2,000	2,348

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	33.86	20.72	19.79	32.87	18.47	36.32
Accrued Expenses	5.74	8.03	8.21	17.56	31.34	25.8
Current Portion of Leases	6.49	3.04	4.11	4.29	3.73	3.31
Current Income Taxes Payable	19.54	1.56	1.04	2.17	2	2.08
Current Unearned Revenue	11.3	10.38	10.27	10.86	7.91	8.2
Other Current Liabilities	361.07	43	37.78	38.63	89.57	103.49
Total Current Liabilities	438	86.73	81.2	106.38	153.01	179.21
Long-Term Debt	976.26	-	-	-	-	-
Long-Term Leases	0.06	1.16	0.72	4.65	8.12	9.82
Long-Term Unearned Revenue	13.78	14.09	14.57	15.5	18.32	19.07
Long-Term Deferred Tax Liabilities	14.03	2.81	6.67	6.45	6.71	3.01
Other Long-Term Liabilities	8.46	0.66	0.68	0.79	33.19	159.19
Total Liabilities	1,451	105.46	103.84	133.77	219.35	370.3

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	544.01	544.01	544.01	544.01	544.01	544.01
Additional Paid-In Capital	610.81	610.81	610.81	610.81	610.81	651.39
Retained Earnings	491.23	484.29	507.28	587.82	572.48	639.63
Total Common Equity	1,646	1,639	1,662	1,743	1,727	1,835
Minority Interest	476.29	31.62	56.48	61.99	53.16	143.08
Shareholders' Equity	2,122	1,671	1,719	1,805	1,780	1,978
Total Liabilities & Equity	3,573	1,776	1,822	1,938	2,000	2,348

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	982.81	4.2	4.83	8.95	11.84	13.13
Net Cash (Debt)	-408.01	898.57	885.58	846.37	786.97	915.47
Net Cash Growth	-	1.47%	4.63%	7.55%	-14.04%	192.03%
Net Cash Per Share	-0.75	1.65	1.63	1.56	1.40	2.04
Filing Date Shares Outstanding	544.01	544.01	544.01	544.01	544.01	544.01
Total Common Shares Outstanding	544.01	544.01	544.01	544.01	544.01	544.01
Working Capital	1,437	1,015	1,026	999.3	957.49	1,100
Book Value Per Share	3.03	3.01	3.06	3.20	3.18	3.37
Tangible Book Value	771.18	1,545	1,563	1,569	1,534	1,607
Tangible Book Value Per Share	1.42	2.84	2.87	2.88	2.82	2.95
Buildings	-	479.36	486.27	495.09	488.24	487.72
Machinery	-	288.13	281.56	253.19	245.25	231.03
Construction In Progress	-	2.09	0.58	0.52	6.4	-

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error